Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Primary and review articles published in English were identified by a MEDLINE (1966-June 2003) search using the MeSH terms "hot flashes," "hot flushes," "menopause," and "serotonin reuptake inhibitor.

But one of the most common complaints during this stage of life is hot flashes. That's why Jennifer Ashton, MD, OB-GYN, a women's health expert specializing in menopause and obesity medicine and ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

In some women, hot flashes are accompanied by anxiety, heart racing, or palpitations, which can interfere with their jobs and relationships,” Hugh Taylor, MD, chair of Yale Medicine Obstetrics ...

But if it can reduce hot flashes sufficiently enough so a woman can get a good night's sleep, that may allow her to cope better." Mary Hardy, MD, medical director of the Integrative Medicine ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning—a black-box warning—for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but ...

Both cognitive-behavioral therapy and clinical hypnosis are among the most effective options not involving medication.

The FDA has issued a black-box warning for Veozah, a hot-flash medication, due to rare but serious liver risks ...

FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning By Denise Maher HealthDay Reporter WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA ...